Health News Roundup: Juul’s e-cigarettes get temporary breather after U.S. FDA order; Panama reports country’s first monkeypox case and more

Following is a abstract of present well being information briefs.
Juul’s e-cigarettes get temporary breather after U.S. FDA order
The U.S. Food and Drug Administration (FDA) stated on Tuesday it has quickly stayed the advertising and marketing denial order on Juul Labs Inc’s e-cigarettes, permitting the merchandise to remain available on the market whereas it appeals the regulator’s ban. Sales of e-cigarettes by Juul, partly owned by tobacco big Altria Group Inc, have been blocked by the U.S. FDA on June 23.
Panama reports country’s first monkeypox case
Panama registered its first case of monkeypox in a resident who was contaminated after being in touch with vacationers from Europe, Panama’s well being ministry stated Tuesday. “Yesterday within the afternoon, the first case of monkeypox in our nation was confirmed,” Health Minister Luis Sucre stated throughout a press convention, including the affected person “is totally secure” and the “case is correctly managed.”
COVID and bust: China’s non-public well being system harm by robust coronavirus controls
On March 24, a court docket within the central Chinese metropolis of Fuyang introduced {that a} $1.5 billion hospital constructed simply 4 years earlier had filed for chapter as a result of it was unable to pay its money owed. For many of the final two years, the Fuyang Minsheng Hospital had been totally concerned in mass coronavirus vaccination and testing applications within the metropolis, coaching nearly 100 employees to carry out throat swabs and organising cell vaccination amenities to go to varsities and workplaces, on the order of metropolis officers.
U.S. FDA to reconvene specialists’ assembly for Amylyx ALS drug
The U.S. Food and Drug Administration will reconvene a gathering of its outdoors specialists to evaluate Amylyx Pharmaceuticals’ software for its amyotrophic lateral sclerosis (ALS) therapy, the corporate stated on Tuesday. A panel of outdoor advisers to the U.S. FDA in March voted six to 4 in opposition to approving the corporate’s oral drug, AMX0035, saying Amylyx’s scientific examine knowledge failed to determine it was efficient in opposition to ALS, a neurodegenerative illness.
China fights COVID flare-ups on a number of fronts together with Shanghai
China is preventing COVID-19 flare-ups on a number of fronts throughout the nation together with an rising cluster in Shanghai, spurring mass testing drives and recent restrictions, as pressures mount on native officers to avert a wider unfold and large disruptions. The total caseload remained small by international requirements with simply over 300 every day native infections, however any additional potential surge in key cities might name for a return of stringent measures below China’s “dynamic COVID zero” coverage and dent confidence within the country’s financial restoration.
Omicron sub-variants BA.4, and BA.5 make up 70% of COVID variants in U.S. – CDC
The fast-spreading BA.4 and BA.5 sub-lineages of Omicron are estimated to make up a mixed 70.1% of the coronavirus variants within the United States as of July 2, the U.S. Centers for Disease Control and Prevention stated on Tuesday. BA.4 and BA.5 made up 52% of U.S. variants for the week of June 25. They have been added to the World Health Organization’s monitoring checklist in March and designated as variants of concern by the European Centre for Disease Prevention and Control.
Macau locks down landmark Lisboa lodge after COVID instances discovered
Macau has locked down one of many metropolis’s most well-known accommodations, the Grand Lisboa, after more than a dozen COVID-19 instances have been discovered there on Tuesday, with infections spreading quickly on this planet’s greatest playing hub. At least 16 different buildings throughout the particular Chinese administrative area are additionally locked down with nobody allowed to exit or enter.
CureVac information patent lawsuit in Germany in opposition to BioNTech over mRNA expertise
CureVac has filed a patent lawsuit in Germany in opposition to BioNTech over its use of mRNA expertise, marking one of many first identified instances of an organization going to court docket amid the fierce competitors to develop a vaccine in opposition to the coronavirus. The German-based biotech firm is searching for “honest compensation” from BioNTech and two subsidiaries for infringement of its mental property rights, it stated on Tuesday.
FDA choice on Eisai, Biogen Alzheimer’s drug due in January
The U.S. Food and Drug Administration will expedite its evaluate of Eisai Co Ltd’s and Biogen Inc’s experimental Alzheimer’s drug lecanemab, with a call due by Jan 6, 2023, the businesses stated on Tuesday. Lecanemab, just like the companions’ earlier drug Aduhelm, is an antibody designed to take away sticky deposits of a protein referred to as amyloid-beta from the brains of individuals with early Alzheimer’s, a illness that results in reminiscence loss and the lack to take care of oneself.
Italy’s every day coronavirus instances exceed 100,000 for the first time since Feb. – well being ministry
Italy reported 132,274 COVID-19 instances on Tuesday, a well being ministry official figures confirmed, surpassing 100,000 for the first time since Feb. 8. Italy, whose loss of life tally because the starting of the pandemic is the eight-highest on this planet, additionally reported 94 deaths on Tuesday. (With inputs from companies.)

Recommended For You